# CoastalSouth Bancshares, Inc.: financial statements, quarterly

COSO · NYSE · CIK 1297107 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/coso.md) · [Financials](/companies/coso/financials.md) · [Filings](/companies/coso/filings.md) · [Insiders](/companies/coso/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/coso/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [528](/filings/0001297107-25-000006.md) | [427](/filings/0001193125-25-272276.md) | [467 d](/filings/0001193125-26-104114.md) | [497](/filings/0001193125-26-214695.md) | [487](/filings/0001297107-26-000014.md) | [464](/filings/0001193125-25-272276.md) | [537 d](/filings/0001193125-26-104114.md) | [519](/filings/0001193125-26-214695.md) | [509](/filings/0001297107-26-000014.md) |
| Income tax | $k | [1,577](/filings/0001297107-25-000006.md) | [2,236](/filings/0001193125-25-272276.md) | [950 d](/filings/0001193125-26-104114.md) | [1,542](/filings/0001193125-26-214695.md) | [1,064](/filings/0001297107-26-000014.md) | [2,040](/filings/0001193125-25-272276.md) | [1,598 d](/filings/0001193125-26-104114.md) | [1,956](/filings/0001193125-26-214695.md) | [1,502](/filings/0001297107-26-000014.md) |
| Net income | $k | [5,887](/filings/0001297107-25-000006.md) | [7,884](/filings/0001193125-25-272276.md) | [5,704 d](/filings/0001193125-26-104114.md) | [5,050](/filings/0001193125-26-214695.md) | [5,965](/filings/0001297107-26-000014.md) | [6,741](/filings/0001193125-25-272276.md) | [7,136 d](/filings/0001193125-26-104114.md) | [6,329](/filings/0001193125-26-214695.md) | [7,333](/filings/0001297107-26-000014.md) |
| Diluted EPS | $ per share | [0.56](/filings/0001297107-25-000006.md) | [0.75](/filings/0001193125-25-272276.md) | not reported | [0.47](/filings/0001193125-26-214695.md) | [0.57](/filings/0001297107-26-000014.md) | [0.54](/filings/0001193125-25-272276.md) | not reported | [0.51](/filings/0001193125-26-214695.md) | [0.59](/filings/0001297107-26-000014.md) |
| Basic EPS | $ per share | [0.58](/filings/0001297107-25-000006.md) | [0.77](/filings/0001193125-25-272276.md) | not reported | [0.49](/filings/0001193125-26-214695.md) | [0.58](/filings/0001297107-26-000014.md) | [0.57](/filings/0001193125-25-272276.md) | not reported | [0.53](/filings/0001193125-26-214695.md) | [0.61](/filings/0001297107-26-000014.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | not reported | not reported | not reported | not reported | [2,099](/filings/0001193125-26-104114.md) | not reported | [2,221](/filings/0001297107-25-000006.md) | [2,255](/filings/0001193125-25-272276.md) | [2,307](/filings/0001297107-26-000014.md) | [2,349](/filings/0001193125-26-214695.md) | [2,421](/filings/0001297107-26-000014.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [1,903](/filings/0001193125-26-104114.md) | not reported | [2,012](/filings/0001297107-25-000006.md) | [2,005](/filings/0001193125-25-272276.md) | [2,047](/filings/0001297107-26-000014.md) | [2,086](/filings/0001193125-26-214695.md) | [2,151](/filings/0001297107-26-000014.md) |
| Shareholders' equity | $m | [156](/filings/0001193125-26-104114.md) | [173](/filings/0001297107-25-000006.md) | [180](/filings/0001193125-25-272276.md) | [193](/filings/0001193125-25-272276.md) | [195](/filings/0001297107-26-000014.md) | [202](/filings/0001297107-26-000014.md) | [209](/filings/0001297107-26-000014.md) | [250](/filings/0001193125-25-272276.md) | [260](/filings/0001297107-26-000014.md) | [263](/filings/0001297107-26-000014.md) | [270](/filings/0001297107-26-000014.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.4) d](/filings/0001193125-25-272276.md) | [37.8 d](/filings/0001193125-26-104114.md) | [(1.2)](/filings/0001193125-26-214695.md) | [(15.6) d](/filings/0001297107-26-000014.md) | [(5.5) d](/filings/0001193125-25-272276.md) | [85.5 d](/filings/0001193125-26-104114.md) | [(20.6)](/filings/0001193125-26-214695.md) | [9.8 d](/filings/0001297107-26-000014.md) |
| Capital expenditure | $m | [0.7 d](/filings/0001193125-25-272276.md) | [0.3 d](/filings/0001193125-26-104114.md) | [0.4](/filings/0001193125-26-214695.md) | [0.7 d](/filings/0001297107-26-000014.md) | [0.4 d](/filings/0001193125-25-272276.md) | [0.3 d](/filings/0001193125-26-104114.md) | [1.1](/filings/0001193125-26-214695.md) | [0.2 d](/filings/0001297107-26-000014.md) |
| Dividends paid | $m | not reported | not reported | [0.0](/filings/0001193125-26-214695.md) | [0.0 d](/filings/0001297107-26-000014.md) | not reported | not reported | [0.6](/filings/0001193125-26-214695.md) | [0.6 d](/filings/0001297107-26-000014.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.4](/filings/0001297107-25-000006.md) | [10.5](/filings/0001193125-25-272276.md) | [10.6](/filings/0001193125-26-214695.md) | [10.6](/filings/0001297107-26-000014.md) | [12.3](/filings/0001193125-25-272276.md) | [12.4](/filings/0001193125-26-214695.md) | [12.4](/filings/0001297107-26-000014.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,954,446 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001297107-26-000014.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.